Your browser doesn't support javascript.
loading
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.
Takezako, Naoki; Shibayama, Hirohiko; Handa, Hiroshi; Hagiwara, Shotaro; Ozaki, Shuji; Suzuki, Kenshi; Kosugi, Hiroshi; Ri, Masaki; Sugiura, Isamu; Choi, Ilseung; Miyamoto, Toshihiro; Iida, Shinsuke.
  • Takezako N; National Hospital Organization Disaster Medical Center, 3256 Midori, Tachikawa, Tokyo, 190-0014, Japan. ntakezak@tdmc.hosp.go.jp.
  • Shibayama H; Osaka University Graduate School of Medicine, Suita, Japan.
  • Handa H; Gunma University Graduate School, Maebashi, Japan.
  • Hagiwara S; Tokyo Women's University, Tokyo, Japan.
  • Ozaki S; Tokushima Prefectural Central Hospital, Tokushima, Japan.
  • Suzuki K; Japanese Red Cross Medical Center, Tokyo, Japan.
  • Kosugi H; Ogaki Municipal Hospital, Ogaki, Japan.
  • Ri M; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Sugiura I; Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Choi I; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Miyamoto T; Kyushu University Hospital, Fukuoka, Japan.
  • Iida S; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Int J Hematol ; 113(2): 219-230, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33037990
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Inhibidores de Proteasoma / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Inhibidores de Proteasoma / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article